Introduction: Hypoxic ischemic encephalopathy (HIE) is the most important reason for
morbidity and mortality in term-born infants. Understanding pathophysiology of the brain …

Background There is widespread, increasing use of magnesium sulphate in obstetric
practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for …

Differences in the development of the male and female brain are an evolving area of
investigation. We are beginning to understand the underpinnings of male and female …

Ischemic encephalopathy is associated with a high mortality and rate of disability. The most
common type of ischemic encephalopathy, ischemic stroke, is the second leading cause of …

Clinical service, educational, and research components of a fetal/neonatal neurology
program are anchored by the disciplines of developmental origins of health and disease and …

Introduction To evaluate the effect of antenatal magnesium sulfate (MgSO4) on mortality and
morbidity outcomes related to the gastrointestinal system (GI) in preterm infants. Methods …

Hypoxic–ischemic (HI) brain injury in newborns results in serious damage. Magnesium
sulfate has been clinically used as a cyto-protective agent against HI brain injury in …

Objective The aim of this systematic review and meta-analysis study was to determine the
pooled estimate of the effect of antenatal magnesium sulfate (MgSO 4) on intraventricular …

Magnesium sulfate is a versatile therapeutic agent in maternal-fetal medicine, and its use
during pregnancy has led to various clinical scenarios. This comprehensive review …

Background: Magnesium sulphate (MgSO 4) is routinely administered to pregnant women
as a tocolytic and as a neuroprotective agent against cerebral palsy and motor impairment in …